Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 23 Jun 2023 for DICE Therapeutics, Inc., €83.6M. Read the official filing
Filing timeline
BuySaleNorthpond Ventures GP, LLC
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Northpond Ventures GP, LLC: trading record in brief
Northpond Ventures GP, LLC has filed trades across 3 companies (mainly through SEC (Form 4)), most often in DICE Therapeutics, Inc., Telesis Bio Inc. and Vigil Neuroscience, Inc. Over a trading history stretching from 22 June 2021 to 22 June 2023, the count stands at 4 filings.
On the market, this insider has only sold: 1 sale, €83.6M in total. 2023 to date brings no purchases and 1 sale.
The latest filing, published on 23 June 2023, reports an open-market sale of €83.6M in DICE Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Northpond Ventures GP, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
1,969,368 shares@ US$46.50100.0% of flowCommon StockSEC:0000899243-23-016413:0
2,831,520 sharesCommon StockSEC:0000899243-22-001631:0
2,603,075 sharesCommon StockSEC:0000899243-21-036646:0
9,375,380 sharesCommon StockSEC:0000899243-21-025745:0
4 of 4 declarations
